リピドミクスの世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2431)
◆英語タイトル:Global Lipidomics Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2431
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥518,700見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥778,050見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,037,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、リピドミクスの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(血液サンプル、組織サンプル、その他)、用途別市場規模(創薬、バイオマーカー発見、個別化医療、診断・治療、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・リピドミクスの市場動向
・企業の競争状況、市場シェア
・リピドミクスの種類別市場規模(血液サンプル、組織サンプル、その他)
・リピドミクスの用途別市場規模(創薬、バイオマーカー発見、個別化医療、診断・治療、その他)
・リピドミクスの北米市場規模2016-2027(アメリカ、カナダ)
・リピドミクスの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・リピドミクスのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・リピドミクスの中南米市場規模2016-2027(メキシコ、ブラジル)
・リピドミクスの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Zora Biosciences OY、Owl Metabolomics、Avanti Lipids Polar, Inc.、The Metabolomics Innovation Centre、Lipotype GmbH、Metabolon, Inc.、Waters Corporation、Creative Proteomics、Thermo Fisher Scientific、MetaSysX)
・結論
【レポートの概要】

Lipidomics is a developing biomedical research discipline that includes complex lipidome analysis. It is a quantitative and comprehensive description of a collection of lipid species in an organism. Lipidomics compromises system-level quantitation and identifies several networks and cellular lipids and interaction pathways with distinct proteins and moieties.

Market Analysis and Insights: Global Lipidomics Market
The global Lipidomics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lipidomics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lipidomics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lipidomics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lipidomics market.

Global Lipidomics Scope and Market Size
Lipidomics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lipidomics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Blood Sample
Tissue Sample
Others

Segment by Application
Drug Discovery
Biomarker Discovery
Personalized Medicine
Diagnosis and Treatment
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Zora Biosciences OY
Owl Metabolomics
Avanti Lipids Polar, Inc.
The Metabolomics Innovation Centre
Lipotype GmbH
Metabolon, Inc.
Waters Corporation
Creative Proteomics
Thermo Fisher Scientific
MetaSysX

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lipidomics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Sample
1.2.3 Tissue Sample
1.2.4 Others
1.3 Market by Application
1.3.1 Global Lipidomics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drug Discovery
1.3.3 Biomarker Discovery
1.3.4 Personalized Medicine
1.3.5 Diagnosis and Treatment
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lipidomics Market Perspective (2016-2027)
2.2 Lipidomics Growth Trends by Regions
2.2.1 Lipidomics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lipidomics Historic Market Share by Regions (2016-2021)
2.2.3 Lipidomics Forecasted Market Size by Regions (2022-2027)
2.3 Lipidomics Industry Dynamic
2.3.1 Lipidomics Market Trends
2.3.2 Lipidomics Market Drivers
2.3.3 Lipidomics Market Challenges
2.3.4 Lipidomics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lipidomics Players by Revenue
3.1.1 Global Top Lipidomics Players by Revenue (2016-2021)
3.1.2 Global Lipidomics Revenue Market Share by Players (2016-2021)
3.2 Global Lipidomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lipidomics Revenue
3.4 Global Lipidomics Market Concentration Ratio
3.4.1 Global Lipidomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lipidomics Revenue in 2020
3.5 Lipidomics Key Players Head office and Area Served
3.6 Key Players Lipidomics Product Solution and Service
3.7 Date of Enter into Lipidomics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lipidomics Breakdown Data by Type
4.1 Global Lipidomics Historic Market Size by Type (2016-2021)
4.2 Global Lipidomics Forecasted Market Size by Type (2022-2027)

5 Lipidomics Breakdown Data by Application
5.1 Global Lipidomics Historic Market Size by Application (2016-2021)
5.2 Global Lipidomics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lipidomics Market Size (2016-2027)
6.2 North America Lipidomics Market Size by Type
6.2.1 North America Lipidomics Market Size by Type (2016-2021)
6.2.2 North America Lipidomics Market Size by Type (2022-2027)
6.2.3 North America Lipidomics Market Size by Type (2016-2027)
6.3 North America Lipidomics Market Size by Application
6.3.1 North America Lipidomics Market Size by Application (2016-2021)
6.3.2 North America Lipidomics Market Size by Application (2022-2027)
6.3.3 North America Lipidomics Market Size by Application (2016-2027)
6.4 North America Lipidomics Market Size by Country
6.4.1 North America Lipidomics Market Size by Country (2016-2021)
6.4.2 North America Lipidomics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Lipidomics Market Size (2016-2027)
7.2 Europe Lipidomics Market Size by Type
7.2.1 Europe Lipidomics Market Size by Type (2016-2021)
7.2.2 Europe Lipidomics Market Size by Type (2022-2027)
7.2.3 Europe Lipidomics Market Size by Type (2016-2027)
7.3 Europe Lipidomics Market Size by Application
7.3.1 Europe Lipidomics Market Size by Application (2016-2021)
7.3.2 Europe Lipidomics Market Size by Application (2022-2027)
7.3.3 Europe Lipidomics Market Size by Application (2016-2027)
7.4 Europe Lipidomics Market Size by Country
7.4.1 Europe Lipidomics Market Size by Country (2016-2021)
7.4.2 Europe Lipidomics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lipidomics Market Size (2016-2027)
8.2 Asia-Pacific Lipidomics Market Size by Type
8.2.1 Asia-Pacific Lipidomics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lipidomics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lipidomics Market Size by Type (2016-2027)
8.3 Asia-Pacific Lipidomics Market Size by Application
8.3.1 Asia-Pacific Lipidomics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lipidomics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lipidomics Market Size by Application (2016-2027)
8.4 Asia-Pacific Lipidomics Market Size by Region
8.4.1 Asia-Pacific Lipidomics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lipidomics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lipidomics Market Size (2016-2027)
9.2 Latin America Lipidomics Market Size by Type
9.2.1 Latin America Lipidomics Market Size by Type (2016-2021)
9.2.2 Latin America Lipidomics Market Size by Type (2022-2027)
9.2.3 Latin America Lipidomics Market Size by Type (2016-2027)
9.3 Latin America Lipidomics Market Size by Application
9.3.1 Latin America Lipidomics Market Size by Application (2016-2021)
9.3.2 Latin America Lipidomics Market Size by Application (2022-2027)
9.3.3 Latin America Lipidomics Market Size by Application (2016-2027)
9.4 Latin America Lipidomics Market Size by Country
9.4.1 Latin America Lipidomics Market Size by Country (2016-2021)
9.4.2 Latin America Lipidomics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lipidomics Market Size (2016-2027)
10.2 Middle East & Africa Lipidomics Market Size by Type
10.2.1 Middle East & Africa Lipidomics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lipidomics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lipidomics Market Size by Type (2016-2027)
10.3 Middle East & Africa Lipidomics Market Size by Application
10.3.1 Middle East & Africa Lipidomics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lipidomics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lipidomics Market Size by Application (2016-2027)
10.4 Middle East & Africa Lipidomics Market Size by Country
10.4.1 Middle East & Africa Lipidomics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lipidomics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Zora Biosciences OY
11.1.1 Zora Biosciences OY Company Details
11.1.2 Zora Biosciences OY Business Overview
11.1.3 Zora Biosciences OY Lipidomics Introduction
11.1.4 Zora Biosciences OY Revenue in Lipidomics Business (2016-2021)
11.1.5 Zora Biosciences OY Recent Development
11.2 Owl Metabolomics
11.2.1 Owl Metabolomics Company Details
11.2.2 Owl Metabolomics Business Overview
11.2.3 Owl Metabolomics Lipidomics Introduction
11.2.4 Owl Metabolomics Revenue in Lipidomics Business (2016-2021)
11.2.5 Owl Metabolomics Recent Development
11.3 Avanti Lipids Polar, Inc.
11.3.1 Avanti Lipids Polar, Inc. Company Details
11.3.2 Avanti Lipids Polar, Inc. Business Overview
11.3.3 Avanti Lipids Polar, Inc. Lipidomics Introduction
11.3.4 Avanti Lipids Polar, Inc. Revenue in Lipidomics Business (2016-2021)
11.3.5 Avanti Lipids Polar, Inc. Recent Development
11.4 The Metabolomics Innovation Centre
11.4.1 The Metabolomics Innovation Centre Company Details
11.4.2 The Metabolomics Innovation Centre Business Overview
11.4.3 The Metabolomics Innovation Centre Lipidomics Introduction
11.4.4 The Metabolomics Innovation Centre Revenue in Lipidomics Business (2016-2021)
11.4.5 The Metabolomics Innovation Centre Recent Development
11.5 Lipotype GmbH
11.5.1 Lipotype GmbH Company Details
11.5.2 Lipotype GmbH Business Overview
11.5.3 Lipotype GmbH Lipidomics Introduction
11.5.4 Lipotype GmbH Revenue in Lipidomics Business (2016-2021)
11.5.5 Lipotype GmbH Recent Development
11.6 Metabolon, Inc.
11.6.1 Metabolon, Inc. Company Details
11.6.2 Metabolon, Inc. Business Overview
11.6.3 Metabolon, Inc. Lipidomics Introduction
11.6.4 Metabolon, Inc. Revenue in Lipidomics Business (2016-2021)
11.6.5 Metabolon, Inc. Recent Development
11.7 Waters Corporation
11.7.1 Waters Corporation Company Details
11.7.2 Waters Corporation Business Overview
11.7.3 Waters Corporation Lipidomics Introduction
11.7.4 Waters Corporation Revenue in Lipidomics Business (2016-2021)
11.7.5 Waters Corporation Recent Development
11.8 Creative Proteomics
11.8.1 Creative Proteomics Company Details
11.8.2 Creative Proteomics Business Overview
11.8.3 Creative Proteomics Lipidomics Introduction
11.8.4 Creative Proteomics Revenue in Lipidomics Business (2016-2021)
11.8.5 Creative Proteomics Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Lipidomics Introduction
11.9.4 Thermo Fisher Scientific Revenue in Lipidomics Business (2016-2021)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 MetaSysX
11.10.1 MetaSysX Company Details
11.10.2 MetaSysX Business Overview
11.10.3 MetaSysX Lipidomics Introduction
11.10.4 MetaSysX Revenue in Lipidomics Business (2016-2021)
11.10.5 MetaSysX Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ リピドミクスの世界市場規模・現状・予測2021年-2027年(Global Lipidomics Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。